TEPLIZUMAB
Drug Details
- Generic Name
- TEPLIZUMAB
- Brand Names
- N/A
- Application Number
- Sponsor
- AGC Biologics, Inc.
- NDC Codes
- 1
- Dosage Forms
- SOLUTION
- Routes
- N/A
- Active Ingredients
- TEPLIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE TZIELD is indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients 1 year of age and older with Stage 2 type 1 diabetes [see Dosage and Administration (2.1) ] . TZIELD is a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients 1 year of age and older with Stage 2 T1D ( 1 ).